Author

Ping Qü

University of PennsylvaniaORCID 0009-0005-6442-6558Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetics· 1 Genomics· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1

Frequent Co-Authors

Kiran MusunuruiD· 3 shared Mohamad‐Gabriel AlamehiD· 3 shared Xiao WangiD· 3 shared Aidan Quigley· 2 shared Hooda SaidiD· 2 shared Ishaan JindaliD· 2 shared Lauren C. TestaiD· 2 shared Madelynn N. WhittakeriD· 2 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersGenetics

Kiran MusunuruORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

GeneticsbioRxivPreprintMar 15, 2026

Correction of a recurrent pathogenic variant in methylmalonic acidemia using adenine base editing

Elena Kahn, Hooda Said, Ping Qü…·Rebecca C. Ahrens‐Nicklas

This study corrects a common pathogenic variant in MMA using adenine base editing in hepatocytes, showing efficient in vitro editing with minimal off-target effects.

DOI 10.64898/2026.03.12.711365

humanexperimental assay

𝕏 PostBluesky

Molecular BiologybioRxivPreprintApr 22, 2024

Improved specificity and efficiency of in vivo adenine base editing therapies with hybrid guide RNAs

Madelynn N. Whittaker, Lauren C. Testa, Dominique L. Brooks…·Xiao Wang

This study evaluates hybrid guide RNAs to improve the specificity and efficiency of adenine base editing therapies for genetic disorders.

3 citations

humanmouse

𝕏 PostBluesky

GenomicsArteriosclerosis Thrombosis and Vascular BiologyPeer-reviewedAug 17, 2023

Epigenome Editing Durability Varies Widely Across Cardiovascular Disease Target Genes

Madelynn N. Whittaker, Lauren C. Testa, Aidan Quigley…·Xiao Wang

This study evaluates the durability of epigenome editing for reducing gene expression in cardiovascular disease targets, finding durable effects for PCSK9 but not for ANGPTL3 or AGT.

19 citations

humanDNA methylation

𝕏 PostBluesky